This comes at no additional cost to the reader
Currently, Wegovy is FDA approved for the following: Children ages 12 years or older with a body mass index (BMI) at or above the 95th percentile for their sex and age Adults with a BMI at or above 30 Adults with a BMI at or above 27 and at least one weight-related health condition, such as heart disease, diabetes, high blood pressure, or sleep apnea Adults with a BMI at or above 27 with established cardiovascular disease and a risk of major adverse cardiovascular events (like heart attack or stroke) Adults with noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver fibrosis Note that there are slightly different prescribing rules for Wegovy pills versus Wegovy injections
uniquely, the program reimburses payers should patients not achieve and then maintain weight loss following deprescription, allowing payers to avoid losses
Those who persist through this window typically find improvement ahead
When the biology gets more nuanced, the record keeping has to get more disciplined
You're guaranteeing your solution will be compromised by the end
